Organization
United States Food and Drug Administration
Latest reports
- FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic
Business LineIN31 outlets
Add to CRM
- Novo, Lilly drugs to carry new FDA eye risk warning
nashvilleherald.comStory
Add to CRM - FDA orders eye risk warnings for Ozempic, Zepbound
Big News NetworkAE2 outlets
Add to CRM - تسبب العمى.. إدارة الغذاء والدواء الأمريكية تحذر من حقن التخسيس
Blindness caused.. US FDA warns against weight loss injections
Sada El BaladEG2 outlets
Add to CRM
- “시력 줄어들 위험 있다” 식약처, GLP-1 비만치료제 안전성 서한 배포
Food and Drug Administration distributes letter on safety of GLP-1 obesity treatment
Kormedi.comKR2 outlets
Add to CRM
- 비만치료제 투여 뒤 시력 이상 땐?…식약처, 주의 당부
What to do if you experience vision problems after taking obesity medication?... FDA issues warning
Segye IlboKRStory
Add to CRM